Literature DB >> 29657889

Pre-operative versus post-operative radiosurgery for brain metastasis: Effects on treatment volume and inter-observer variability.

B A Vellayappan1, J Doody2, E Vandervoort2, J Szanto2, J Sinclair3, J M Caudrelier2, S Malone2.   

Abstract

PURPOSE/
OBJECTIVES: Compared to post-operative whole brain radiotherapy, resection cavity radiosurgery reduces impact on neuro-cognitive function and improves quality-of-life. However, coverage of the operative tract, in addition to tumour bed, may lead to large treatment volumes and inter-observer variability. We hypothesized that pre-operative radiosurgery reduces target volume size and inter-observer variability compared to post-operative radiosurgery. MATERIALS/
METHODS: We identified 10 consecutive patients, with solitary brain metastasis, treated with post-operative cavity radiosurgery.Pre- and post-operative axial T1 contrast MRI were co-registered with the planning CT scans. Three radiation oncologists independently contoured the target volumes on the pre- and post-operative imaging. A 2mm-PTV margin was utilized for both strategies and radiosurgery treatment plans were generated. The following parameters were evaluated in the 2 plans: Mean target volume (cc), 50% isodose volume (cc), Inter-observer variability (Jaccard Index JI) and Conformity Index (CI).
RESULTS: There was no significant difference in the mean target volume, nor 50% isodose volume, between pre- and post-operative strategies. (17.6 (95% CI 9.98 - 25.22) versus 19.4 (95% CI 10.11 - 28.69) cc, P=0.80; 61.7 (95% CI 38.4 - 85.0) vs 77.7 (95% CI 34.94 - 120.46) cc, P=0.65). There was significantly less inter-observer variability and improved conformity in the pre-operative group (Mean JI 0.84(95% CI 0.82 - 0.86) versus 0.70 (95% CI 0.62 - 0.78), P = 0.005; Mean CI 1.32 (95% CI 1.26 - 1.38) vs 1.45 (95% CI 1.36 - 1.54), P= 0.01). Planned subgroup analysis did not reveal any significant difference (between pre- vs post-op) in the mean volume of cystic versus non-cystic metastasis. Deep lesions (>2.5cm from dura) had a larger post-operative target volume (25.8 (95% CI 15.1 - 36.5) vs 12.3 (95% CI 6.54 - 18.06) cc, P=0.06) compared to superficial lesions.
CONCLUSION: Pre-operative radiosurgery has less inter-observer variability and improved plan conformity. However, there was no difference in mean target volume between the pre- versus post-operative radiation. Contouring guidelines, and peer review, may help to reduce inter-observer variability for cavity radiosurgery.

Entities:  

Keywords:  adjuvant; brain metastasis; pre-operative; radiosurgery

Year:  2018        PMID: 29657889      PMCID: PMC5893459     

Source DB:  PubMed          Journal:  J Radiosurg SBRT


  23 in total

Review 1.  Geometrical analysis of radiotherapy target volume delineation: a systematic review of reported comparison methods.

Authors:  G G Hanna; A R Hounsell; J M O'Sullivan
Journal:  Clin Oncol (R Coll Radiol)       Date:  2010-09       Impact factor: 4.126

2.  Risk of leptomeningeal disease in patients treated with stereotactic radiosurgery targeting the postoperative resection cavity for brain metastases.

Authors:  Banu Atalar; Leslie A Modlin; Clara Y H Choi; John R Adler; Iris C Gibbs; Steven D Chang; Griffith R Harsh; Gordon Li; Seema Nagpal; Alexandra Hanlon; Scott G Soltys
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-09-18       Impact factor: 7.038

3.  A new treatment paradigm: neoadjuvant radiosurgery before surgical resection of brain metastases with analysis of local tumor recurrence.

Authors:  Anthony L Asher; Stuart H Burri; Walter F Wiggins; Renee P Kelly; Margaret O Boltes; Melissa Mehrlich; H James Norton; Robert W Fraser
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-03-15       Impact factor: 7.038

4.  A phase 2 trial of stereotactic radiosurgery boost after surgical resection for brain metastases.

Authors:  Cameron Brennan; T Jonathan Yang; Patrick Hilden; Zhigang Zhang; Kelvin Chan; Yoshiya Yamada; Timothy A Chan; Stella C Lymberis; Ashwatha Narayana; Viviane Tabar; Philip H Gutin; Åse Ballangrud; Eric Lis; Kathryn Beal
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-01-01       Impact factor: 7.038

5.  Surgical Resection of Brain Metastases and the Risk of Leptomeningeal Recurrence in Patients Treated With Stereotactic Radiosurgery.

Authors:  Matthew D Johnson; Vladimir Avkshtol; Andrew M Baschnagel; Kurt Meyer; Hong Ye; Inga S Grills; Peter Y Chen; Ann Maitz; Rick E Olson; Daniel R Pieper; Daniel J Krauss
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-11-19       Impact factor: 7.038

6.  Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial.

Authors:  Paul D Brown; Kurt Jaeckle; Karla V Ballman; Elana Farace; Jane H Cerhan; S Keith Anderson; Xiomara W Carrero; Fred G Barker; Richard Deming; Stuart H Burri; Cynthia Ménard; Caroline Chung; Volker W Stieber; Bruce E Pollock; Evanthia Galanis; Jan C Buckner; Anthony L Asher
Journal:  JAMA       Date:  2016-07-26       Impact factor: 56.272

7.  Irradiated volume as a predictor of brain radionecrosis after linear accelerator stereotactic radiosurgery.

Authors:  Brian J Blonigen; Ryan D Steinmetz; Linda Levin; Michael A Lamba; Ronald E Warnick; John C Breneman
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-09-23       Impact factor: 7.038

8.  Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial.

Authors:  Eric L Chang; Jeffrey S Wefel; Kenneth R Hess; Pamela K Allen; Frederick F Lang; David G Kornguth; Rebecca B Arbuckle; J Michael Swint; Almon S Shiu; Moshe H Maor; Christina A Meyers
Journal:  Lancet Oncol       Date:  2009-10-02       Impact factor: 41.316

9.  Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis.

Authors:  Giuseppe Minniti; Enrico Clarke; Gaetano Lanzetta; Mattia Falchetto Osti; Guido Trasimeni; Alessandro Bozzao; Andrea Romano; Riccardo Maurizi Enrici
Journal:  Radiat Oncol       Date:  2011-05-15       Impact factor: 3.481

10.  Brain metastases admissions in Sweden between 1987 and 2006.

Authors:  K E Smedby; L Brandt; M L Bäcklund; P Blomqvist
Journal:  Br J Cancer       Date:  2009-10-13       Impact factor: 7.640

View more
  4 in total

Review 1.  Neoadjuvant Stereotactic Radiosurgery: a Further Evolution in the Management of Brain Metastases.

Authors:  Cristian Udovicich; Claire Phillips; David L Kok; Damien Tange; Nikki M Plumridge; Roshan S Prabhu; Neda Haghighi
Journal:  Curr Oncol Rep       Date:  2019-07-04       Impact factor: 5.075

2.  SEOR SBRT-SG survey on SRS/SBRT dose prescription criteria in Spain.

Authors:  M J Perez-Calatayud; A J Conde-Moreno; F J Celada-Álvarez; C Rubio; F López-Campos; A Navarro-Martin; L Arribas; M Santos; J Lopez-Torrecilla; J Perez-Calatayud
Journal:  Clin Transl Oncol       Date:  2021-03-17       Impact factor: 3.405

Review 3.  Neoadjuvant Stereotactic Radiotherapy for Brain Metastases: Systematic Review and Meta-Analysis of the Literature and Ongoing Clinical Trials.

Authors:  Paolo Palmisciano; Gianluca Ferini; Ramlah Khan; Othman Bin-Alamer; Giuseppe E Umana; Kenny Yu; Aaron A Cohen-Gadol; Tarek Y El Ahmadieh; Ali S Haider
Journal:  Cancers (Basel)       Date:  2022-09-04       Impact factor: 6.575

Review 4.  Radiation Necrosis from Stereotactic Radiosurgery-How Do We Mitigate?

Authors:  Balamurugan A Vellayappan; Tresa McGranahan; Jerome Graber; Lynne Taylor; Vyshak Venur; Richard Ellenbogen; Andrew E Sloan; Kristin J Redmond; Matthew Foote; Samuel T Chao; John H Suh; Eric L Chang; Arjun Sahgal; Simon S Lo
Journal:  Curr Treat Options Oncol       Date:  2021-06-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.